Effect of rotavirus genetic diversity on vaccine impact.
gastroenteritis
genotypes
globally
rotavirus vaccination
rotaviruses
Journal
Reviews in medical virology
ISSN: 1099-1654
Titre abrégé: Rev Med Virol
Pays: England
ID NLM: 9112448
Informations de publication
Date de publication:
01 2022
01 2022
Historique:
received:
07
12
2020
accepted:
05
05
2021
entrez:
8
1
2022
pubmed:
9
1
2022
medline:
20
4
2022
Statut:
ppublish
Résumé
Group A rotaviruses (RVAs) are the leading cause of gastroenteritis, causing 0.2 million deaths and several million hospitalisations globally each year. Four rotavirus vaccines (Rotarix
Substances chimiques
Rotavirus Vaccines
0
Vaccines, Attenuated
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
e2259Informations de copyright
© 2021 John Wiley & Sons Ltd.
Références
Alaoui Amine S, Melloul M, El Alaoui MA, et al. Evidence for zoonotic transmission of species A rotavirus from goat and cattle in nomadic herds in Morocco, 2012-2014. Virus Gene. 2020;56(5):582-593.https://doi.org/10.1007/s11262-020-01778-w
Troeger C, Khalil IA, Rao PC, et al. Rotavirus vaccination and the global burden of rotavirus diarrhea among children younger than 5 years. JAMA Pediatr. 2018;172(10):958-965.
Kirkwood CD, Steele AD. Rotavirus vaccine will have an impact in Asia. PLOS Med. 2017;14(5):e1002298
Burke RM, Tate JE, Kirkwood CD, Steele AD, Parashar UD. Current and new rotavirus vaccines Curr Opin Infect Dis. 2019;32:435-444. Available from http://pmc/articles/PMC6749957/?report=abstract
Godfrey O, Zhang W, Amponsem-Boateng C, Oppong TB, Zhao QL, Li D. Evidence of rotavirus vaccine impact in sub-Saharan Africa: systematic review and meta-analysis. PLoS One. 2020;15(4):e0232113. Available from http://pmc/articles/PMC7185587/?report=abstract
Barros BdCVd, Chagas EN, Bezerra LW, et al. Rotavirus A in wild and domestic animals from areas with environmental degradation in the Brazilian Amazon. PLoS ONE. 2018;13(12):e0209005. https://doi.org/10.1371/journal.pone.0209005
Santos FS, Sousa Junior EC, Guerra SFS, et al. G1P[8] Rotavirus in children with severe diarrhea in the post-vaccine introduction era in Brazil: evidence of reassortments and structural modifications of the antigenic VP7 and VP4 regions. Infect Genet Evol. 2019;69:255-266. Available from https://pubmed.ncbi.nlm.nih.gov/30763774/
Kuang X, Gong X, Zhang X, Pan H, Teng Z. Genetic diversity of group A rotavirus in acute gastroenteritis outpatients in Shanghai from 2017 to 2018. BMC Infect Dis. 2020;20:596. Available from https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-020-05279-x
El-Senousy WM, Abu Senna ASM, Mohsen NA, et al. Clinical and environmental surveillance of rotavirus common genotypes showed high prevalence of common P genotypes in Egypt. Food Environ Virol. 2020;12:99-117. https://doi.org/10.1007/s12560-020-09426-0
Matthijnssens J, Ciarlet M, Mcdonald SM, et al. Uniformity of rotavirus strain nomenclature proposed by the rotavirus classification working group (RCWG). Arch Virol. 2011;156(8):1397-1413. Available from https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3398998/pdf/nihms391040.pdf
Rotavirus Classification Working Group. RCWG - laboratory of viral metagenomics. Available from https://rega.kuleuven.be/cev/viralmetagenomics/virus-classification/rcwg. Accessed Jan 10, 2021.
Matthijnssens J, Ciarlet M, Rahman M, et al. Recommendations for the classification of group A rotaviruses using all 11 genomic RNA segments. Arch Virol. 2008;153(8):1621-1629.
Komoto S, Pongsuwanna Y, Ide T, et al. Whole genomic analysis of porcine G10P[5] rotavirus strain P343 provides evidence for bovine-to-porcine interspecies transmission. Vet Microbiol. 2014;174(3-4):577-583. Available from https://pubmed.ncbi.nlm.nih.gov/25457370/
Matthijnssens J, Ciarlet M, Heiman E, et al. Full genome-based classification of rotaviruses reveals a common origin between human Wa-Like and porcine rotavirus strains and human DS-1-like and bovine rotavirus strains. J Virol. 2008;82(7):3204-3219. Available from http://jvi.asm.org/cgi/doi/10.1128/JVI.02257-07
He B, Huang X, Zhang F, et al. Group A rotaviruses in Chinese bats: genetic composition, serology, and evidence for bat-to-human transmission and reassortment. J Virol. 2017;91(12):e02493-16. Available from https://pubmed.ncbi.nlm.nih.gov/28381569/
McDonald SM, McKell AO, Rippinger CM, et al. Diversity and relationships of cocirculating modern human rotaviruses revealed using large-scale comparative genomics. J Virology. 2012;86(17):9148-9162.
Malakalinga JJ, Misinzo G, Msalya GM, Kazwala RR. Rotavirus burden, genetic diversity and impact of vaccine in children under five in Tanzania. Pathogens. 2019;8(4):210.
Sadiq A, Bostan N, Bokhari H, et al. Molecular characterization of human group A rotavirus genotypes circulating in Rawalpindi, Islamabad, Pakistan during 2015-2016. In: Lin B, ed. PLoS One. 2019;14(7):e0220387. Available from http://dx.plos.org/10.1371/journal.pone.0220387
Jiang V, Jiang B, Tate J, Parashar UD, Patel MM. Performance of rotavirus vaccines in developed and developing countries. Hum Vaccin. 2010;6(7):532-542. Available from http://www.ncbi.nlm.nih.gov/pubmed/20622508
Lestari FB, Vongpunsawad S, Wanlapakorn N, Poovorawan Y. Rotavirus infection in children in Southeast Asia 2008-2018: disease burden, genotype distribution, seasonality, and vaccination. J Biomed Sci. 2020;27:1-19. Available from http://pmc/articles/PMC7239768/?report=abstract
Tharmaphornpilas P, Jiamsiri S, Boonchaiya S, et al. Evaluating the first introduction of rotavirus vaccine in Thailand: moving from evidence to policy. Vaccine. 2017;35(5):796-801.
Patel MM, Steele D, Gentsch JR, Wecker J, Glass RI, Parashar UD. Real-world impact of rotavirus vaccination. Pediatr Infect Dis J. 2011;30(SUPPL 1):S1-S5.
Malik YS, Bhat S, Dar PS, Sircar S, Dhama K, Singh RK. Evolving rotaviruses, interspecies transmission and zoonoses. Open Virol J. 2020;14(1):1-6.
Zeller M, Patton JT, Heylen E, et al. Genetic analyses reveal differences in the VP7 and VP4 antigenic epitopes between human rotaviruses circulating in Belgium and rotaviruses in rotarix and RotaTeq. J Clin Microbiol. 2012;50(3):966-976. Available from http://jcm.asm.org/cgi/doi/10.1128/JCM.05590-11
Luchs A, Timenetsky MdCST. Group A rotavirus gastroenteritis: post-vaccine era, genotypes and zoonotic transmission. Einstein (São Paulo). 2016;14(2):278-287.
Sadiq A, Bostan N, Yinda KC, Naseem S, Sattar S. Rotavirus: genetics, pathogenesis and vaccine advances. Rev Med Virol. 2018;28(6):e2003. Available from http://doi.wiley.com/10.1002/rmv.2003
Stubbs SCB, Quaye O, Acquah ME, et al. Full genomic characterization of a porcine rotavirus strain detected in an asymptomatic piglet in Accra, Ghana. BMC Vet Res. 2020;16(1):11. Available from https://bmcvetres.biomedcentral.com/articles/10.1186/s12917-019-2226-9
Valiakos G, Chatzopoulos DC, Tsokana CN. Interspecies transmission of Rotaviruses among ruminants, dogs and humans: current facts and remarks. J Hell Vet Med Soc. 2017;68:123-130. Available from https://ejournals.epublishing.ekt.gr/index.php/jhvms/article/view/15596
Rojas M, Dias HG, Gonçalves JLS, et al. Genetic diversity and zoonotic potential of rotavirus A strains in the southern Andean Highlands, Peru. Transbound Emerg Dis 2019;66(4):tbed.13207. Available from https://onlinelibrary.wiley.com/doi/abs/10.1111/tbed.13207
Phan MVT, Anh PH, Cuong NV, et al. Unbiased whole-genome deep sequencing of human and porcine stool samples reveals circulation ofmultiple groups of rotaviruses and a putative zoonotic infection. Virus Evol. 2016;2(2):vew027. Available from https://pubmed.ncbi.nlm.nih.gov/28748110/
Kumar N, Malik YS, Sharma K, et al. Molecular characterization of unusual bovine rotavirus A strains having high genetic relatedness with human rotavirus: evidence for zooanthroponotic transmission. Zoonoses Public Health. 2018;65(4):431-442. Available from https://pubmed.ncbi.nlm.nih.gov/29464925/
Papp H, Borzák R, Farkas S, et al. Zoonotic transmission of reassortant porcine G4P[6] rotaviruses in Hungarian pediatric patients identified sporadically over a 15 year period. Infect Genet Evol. 2013;19:71-80. Available from https://pubmed.ncbi.nlm.nih.gov/23792183/
Martella V, Bányai K, Matthijnssens J, Buonavoglia C, Ciarlet M. Zoonotic aspects of rotaviruses. Vet Microbiol. 2010;140(3):246-255.
Steyer A, Poljšak-Prijatelj M, Barlič-Maganja D, Marin J. Human, porcine and bovine rotaviruses in Slovenia: evidence of interspecies transmission and genome reassortment. J Gen Virol. 2008;89(7):1690-1698.
Do LP, Kaneko M, Nakagomi T, et al. Molecular epidemiology of Rotavirus A , causing acute gastroenteritis hospitalizations among children in Nha Trang, Vietnam, 2007-2008: identification of rare G9P[19] and G10P[14] strains. J Med Virol. 2017;89(4):621-631. Available from https://pubmed.ncbi.nlm.nih.gov/27611738/
Ianiro G, Micolano R, Conte M, Labianca M, Vaccari G, Monini M. Detection of an animal-derived G4P[6] group A rotavirus strain in a symptomatic child, in Italy. Virus Res. 2019;260:7-11. Available from https://pubmed.ncbi.nlm.nih.gov/30423360/
Bwogi J, Jere KC, Karamagi C, et al. Whole genome analysis of selected human and animal rotaviruses identified in Uganda from 2012 to 2014 reveals complex genome reassortment events between human, bovine, caprine and porcine strains. In: Hozbor DF, ed. PLoS One. 2017;12(6)e0178855. Available from http://www.ncbi.nlm.nih.gov/pubmed/28640820
Sadiq A, Bostan N, Bokhari H, Yinda KC, Matthijnssens J. Whole genome analysis of selected human group A rotavirus strains revealed evolution of DS-1-like single- and double-gene reassortant rotavirus strains in Pakistan during 2015-2016. Front Microbiol. 2019;10:2641.
Fredj MBH, Heylen E, Zeller M, et al. Feline origin of rotavirus strain, Tunisia, 2008. Emerg Infect Dis. 2013;19(4):630-634. Available from http://pmc/articles/PMC3647418/?report=abstract
Park JG, Kim HJ, Matthijnssens J, et al. Different virulence of porcine and porcine-like bovine rotavirus strains with genetically nearly identical genomes in piglets and calves. Vet Res. 2013;44(1):1.
Luchs A, Cilli A, Morillo SG, Carmona RdCC, Timenetsky MdCST. Rare G3P[3] rotavirus strain detected in Brazil: possible human-canine interspecies transmission. J Clin Virology. 2012;54(1):89-92. Available from https://pubmed.ncbi.nlm.nih.gov/22398035/
Jamnikar-Ciglenecki U, Kuhar U, Steyer A, Kirbis A. Whole genome sequence and a phylogenetic analysis of the G8P[14] group A rotavirus strain from roe deer. BMC Vet Res. 2017;13(1):353. Available from https://bmcvetres.biomedcentral.com/articles/10.1186/s12917-017-1280-4
Bonica M, Zeller M, Van Ranst M, Matthijnssens J, Heylen E. Complete genome analysis of a rabbit rotavirus causing gastroenteritis in a human infant. Viruses. 2015;7(2):844-856.
O’Shea H, Mulherin E, Matthijnssens J, et al. Complete genomic sequence analyses of the first group A giraffe rotavirus reveals close evolutionary relationship with rotaviruses infecting other members of the Artiodactyla. Vet Microbiol. 2014;170(1-2):151-156. Available from http://www.ncbi.nlm.nih.gov/pubmed/24582453
Sharma S, Hagbom M, Svensson L, Nordgren J. The impact of human genetic polymorphisms on rotavirus susceptibility, epidemiology, and vaccine take. Viruses. 2020;12(3):324. Available from http://pmc/articles/PMC7150750/?report=abstract
Satayarak J, Strauss ST, Duangdee C, et al. Prevalence and diversity of human rotavirus among Thai adults. J Med Virol. 2020;92(11):2582-2592. Available from https://onlinelibrary.wiley.com/doi/10.1002/jmv.26076
Mwanga MJ, Owor BE, Ochieng JB, et al. Rotavirus group A genotype circulation patterns across Kenya before and after nationwide vaccine introduction, 2010-2018. BMC Infect Dis. 2020;20(1):504. Available from https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-020-05230-0
Matthijnssens J, Bilcke J, Ciarlet M, et al. Rotavirus disease and vaccination: impact on genotype diversity. Future Microbiol. 2009;4(10):1303-1316. Available from https://www.futuremedicine.com/doi/10.2217/fmb.09.96
Komoto S, Adah MI, Ide T, Yoshikawa T, Taniguchi K. Whole genomic analysis of human and bovine G8P[1] rotavirus strains isolated in Nigeria provides evidence for direct bovine-to-human interspecies transmission. Infect Genet Evol. 2016;43:424-433.
Dóró R, László B, Martella V, et al. Review of global rotavirus strain prevalence data from six years post vaccine licensure surveillance: is there evidence of strain selection from vaccine pressure? Infect Genet Evol. 2014;28:446-461.
Patton JT. Rotavirus diversity and evolution in the post-vaccine world. Discov Med. 2012;13(68):85.
Kapikian AZ, Hoshino Y, Chanock RM, Perez-Schael I. Efficacy of a quadrivalent rhesus rotavirus-based human rotavirus vaccine aimed at preventing severe rotavirus diarrhea in infants and young children. J Infect Dis. 1996;174(Suppl 1):S65-S72. Available from: https://academic.oup.com/jid/article/174/Supplement_1/S65/912959
Velázquez RF, Linhares AC, Muñoz S, et al. Efficacy, safety and effectiveness of licensed rotavirus vaccines: a systematic review and meta-analysis for Latin America and the Caribbean. BMC Pediatr. 2017;17(1):1-12. https://doi.org/10.1186/s12887-016-0771-y
Bonaldo G, Noseda R, Ceschi A, Vaccheri A, Motola D. Evaluation of the safety profile of rotavirus vaccines: a pharmacovigilance analysis on American and European data. Sci Rep. 2020;10:13601. https://doi.org/10.1038/s41598-020-70653-3
Tate JE, Mwenda JM, Armah G, et al. Evaluation of intussusception after monovalent rotavirus vaccination in Africa. N Engl J Med. 2018;378(16):1521-1528. Available from https://pubmed.ncbi.nlm.nih.gov/29669224/
Clark A, Tate J, Parashar U, et al. Mortality reduction benefits and intussusception risks of rotavirus vaccination in 135 low-income and middle-income countries: a modelling analysis of current and alternative schedules. Lancet Glob Health. 2019;7(11):e1541-e1552. Available from www.thelancet.com/lancetgh
Sadiq A, Bostan N. Comparative analysis of G1P [ 8 ] rotaviruses identi fi ed prior to vaccine implementation in Pakistan with RotarixTM and RotaTeqTM vaccine strains. Front Immunol. 2020;11(October):2-11.
Santosham M, Steele D. Rotavirus vaccines-a new hope. N Engl J Med. 2017;376(12):1170-1172. Available from http://www.nejm.org/doi/10.1056/NEJMe1701347
Kollaritsch H, Kundi M, Giaquinto C, Paulke-Korinek M. Rotavirus vaccines: a story of success. Clin Microbiol Infect. 2015;21:735-743. Available from https://pubmed.ncbi.nlm.nih.gov/25680314/
Phua KB, Lim FS, Quak S, et al. Efficacy, immunogenicity and safety of a human rotavirus vaccine RIX 4414 in Singaporean infants. Ann Acad Med Singap. 2016;45(2):44-50.
Vesikari T, Matson DO, Dennehy P, et al. Safety and efficacy of a pentavalent human-bovine (WC3) reassortant rotavirus vaccine. N Engl J Med. 2006;354(1):23-33. Available from http://www.nejm.org/doi/10.1056/NEJMoa052664
Ruiz-Palacios GM, Pérez-Schael I, Raúl Velázquez F, et al. Safety and efficacy of an attenuated vaccine against severe rotavirus gastroenteritis. N Engl J Med. 2006;354(1):11-22. Available from www.nejm.org
Bhandari N, Rongsen-Chandola T, Bavdekar A, et al. Efficacy of a monovalent human-bovine (116E) rotavirus vaccine in Indian infants: a randomised, double-blind, placebo-controlled trial. Lancet. 2014;383(9935):2136-2143. Available from https://pubmed.ncbi.nlm.nih.gov/24629994
Coldiron ME, Guindo O, Makarimi R, et al. Safety of a heat-stable rotavirus vaccine among children in Niger: data from a phase 3, randomized, double-blind, placebo-controlled trial. Vaccine. 2018;36(25):3674-3680. Available from https://pubmed.ncbi.nlm.nih.gov/29752026/
Naik SP, Zade JK, Sabale RN, et al. Stability of heat stable, live attenuated Rotavirus vaccine (ROTASIIL®). Vaccine. 2017;35(22):2962-2969. Available from https://pubmed.ncbi.nlm.nih.gov/28434688/
Kulkarni PS, Desai S, Tewari T, et al. A randomized Phase III clinical trial to assess the efficacy of a bovine-human reassortant pentavalent rotavirus vaccine in Indian infants. Vaccine. 2017;35(45):6228-6237. Available from https://pubmed.ncbi.nlm.nih.gov/28967523/
Isanaka S, Guindo O, Langendorf C, et al. Efficacy of a low-cost, heat-stable oral rotavirus vaccine in Niger. N Engl J Med. 2017;376(12):1121-1130. Available from http://www.nejm.org/doi/10.1056/NEJMoa1609462
Nair NP, Reddy SN, Giri S, et al. Rotavirus vaccine impact assessment surveillance in India: protocol and methods. BMJ Open. 2019;9(4):e024840. Available from http://bmjopen.bmj.com/
Kirkwood CD, Ma L-F, Carey ME, Steele AD. The rotavirus vaccine development pipeline. Vaccine. 2019;37:7328-7335. Available from https://doi.org/10.1016/j.vaccine.2017.03.076
WHO. Meeting of the immunization strategic advisory group of experts, April 2009-conclusions and recommendations. Wkly Epidemiol Rec. 2009;84:517-532. Available from http://www.who.int/immunization/newsroom/yaounde_declaration_french.pdf
Madhi SA, Cunliffe NA, Steele D, et al. Effect of human rotavirus vaccine on severe diarrhea in African infants. N Engl J Med. 2010;362(4):289-298. Available from http://www.nejm.org/doi/abs/10.1056/NEJMoa0904797
Armah GE, Sow SO, Breiman RF, et al. Efficacy of pentavalent rotavirus vaccine against severe rotavirus gastroenteritis in infants in developing countries in sub-Saharan Africa: a randomised, double-blind, placebo-controlled trial. Lancet. 2010;376(9741):606-614. Available from http://linkinghub.elsevier.com/retrieve/pii/S0140673610608896
Le LT, Nguyen TV, Nguyen PM, et al. Development and characterization of candidate rotavirus vaccine strains derived from children with diarrhoea in Vietnam. Vaccine. 2009;27(SUPPL 5):F130-F138. Available from https://pubmed.ncbi.nlm.nih.gov/19931712/
Anh DD, Van Trang N, Thiem VD, et al. A dose-escalation safety and immunogenicity study of a new live attenuated human rotavirus vaccine (Rotavin-M1) in Vietnamese children. Vaccine. 2012;30(SUPPL 1):A114-A121. Available from https://pubmed.ncbi.nlm.nih.gov/22520120/
Xia S, Du J, Su J, et al. Efficacy, immunogenicity and safety of a trivalent live human-lamb reassortant rotavirus vaccine (LLR3) in healthy Chinese infants: a randomized, double-blind, placebo-controlled trial. Vaccine. 2020;38(46):7393-7400.
Li D, Xu Z, Xie G, et al. Genotype of rotavirus vaccine strain LLR in China is G10P[15]. Bing Du Xue Bao. 2015;319(2):170-173. Available from https://europepmc.org/article/med/26164943
Fu C, He Q, Xu J, et al. Effectiveness of the Lanzhou lamb rotavirus vaccine against gastroenteritis among children. Vaccine. 2012;31(1):154-158.
Zhen SS, Li Y, Wang SM, et al. Effectiveness of the live attenuated rotavirus vaccine produced by a domestic manufacturer in China studied using a population-based case-control design. Emerg Microbes Infect. 2015;4(10):e64. Available from https://pubmed.ncbi.nlm.nih.gov/26576341/
Bishop RF, Barnes GL, Cipriani E, Lund JS. Clinical immunity after neonatal rotavirus infection. N Engl J Med. 1983;309(2):72-76. Available from https://pubmed.ncbi.nlm.nih.gov/6304516/
Danchin M, Kirkwood CD, Lee KJ, et al. Phase I trial of RV3-BB rotavirus vaccine: a human neonatal rotavirus vaccine. Vaccine. 2013;31(23):2610-2616. Available from https://pubmed.ncbi.nlm.nih.gov/23597719/
Bányai K, László B, Duque J, et al. Systematic review of regional and temporal trends in global rotavirus strain diversity in the pre rotavirus vaccine era: insights for understanding the impact of rotavirus vaccination programs. Vaccine. 2012;30:A122-A130. Available from http://www.ncbi.nlm.nih.gov/pubmed/22520121
Deen J, Lopez AL, Kanungo S, et al. Improving rotavirus vaccine coverage: can newer-generation and locally produced vaccines help? Hum Vaccines Immunother. 2017;14(2):495-499. https://doi.org/10.1080/21645515.2017.1403705
Hwang KP, Wu FT, Bányai K, et al. Identification of porcine rotavirus-like genotype P[6] strains in Taiwanese children. J Med Microbiol. 2012;61(PART 7):990-997. Available from https://pubmed.ncbi.nlm.nih.gov/22466032/
Hu L, Crawford SE, Czako R, et al. Cell attachment protein VP8* of a human rotavirus specifically interacts with A-type histo-blood group antigen. Nature. 2012;485(7397):256-259. Available from https://pubmed.ncbi.nlm.nih.gov/22504179/
Barbé L, Le Moullac-Vaidye B, Echasserieau K, et al. Histo-blood group antigen-binding specificities of human rotaviruses are associated with gastroenteritis but not with in vitro infection. Sci Rep. 2018;8(1):1-14.
Bucardo F, Nordgren J, Reyes Y, Gonzalez F, Sharma S, Svensson L. The Lewis A phenotype is a restriction factor for Rotateq and Rotarix vaccine-take in Nicaraguan children. Sci Rep. 2018;8(1):1-8. Available from www.nature.com/scientificreports
Larsson MM, Rydell GEP, Grahn A, et al. Antibody prevalence and titer to norovirus (genogroup II) correlate with secretor(FUT2)but not with ABO phenotype or Lewis(FUT3)Genotype. J Infect Dis. 2006;194(10):1422-1427. Available from https://academic.oup.com/jid/article-lookup/doi/10.1086/508430
Nordgren J, Nitiema LW, Ouermi D, Simpore J, Svensson L. Host genetic factors affect susceptibility to norovirus infections in Burkina Faso. PLoS One. 2013;8(7):e69557. Available from https://pubmed.ncbi.nlm.nih.gov/23894502/
Corvelo TC, de Loiola Rdo S, Aguiar DC, et al. The Lewis histo-blood group system: molecular analysis of the 59T>G, 508G>A, and 1067T>A polymorphisms in an Amazonian population. In: Veitia RA, ed. PLoS One. 2013;8(7):e69908. Available from https://dx.plos.org/10.1371/journal.pone.0069908
Nordgren J, Sharma S, Kambhampati A, Lopman B, Svensson L. Innate resistance and susceptibility to norovirus infection. In: Dutch RE, ed. PLOS Pathog. 2016;12(4):e1005385. Available from https://dx.plos.org/10.1371/journal.ppat.1005385
Jiang X, Liu Y, Tan M. Histo-blood group antigens as receptors for rotavirus, new understanding on rotavirus epidemiology and vaccine strategy. Emerg Microbes Infect. 2017;6(4):1-8. https://doi.org/10.1038/emi.2017.30
Bines JE, Danchin M, Jackson P, et al. Safety and immunogenicity of RV3-BB human neonatal rotavirus vaccine administered at birth or in infancy: a randomised, double-blind, placebo-controlled trial. Lancet Infect Dis. 2015;15(12):1389-1397. Available from http://www.ncbi.nlm.nih.gov/pubmed/26318715
Clinical Trials. gov. A Phase II Dose-Ranging Study of Oral RV3-BB Rotavirus Vaccine. 2020 [cited 2020 Oct 26]. Available from https://clinicaltrials.gov/ct2/show/NCT03483116
Hoshino Y, Jones RW, Chanock RM, Kapikian AZ. Construction of four double gene substitution human × bovine rotavirus reassortant vaccine candidates: each bears two outer capsid human rotavirus genes, one encoding P serotype 1A and the other encoding G serotype 1, 2, 3, or 4 specificity. J Med Virol. 1997;51(4):319-325. Available from https://onlinelibrary.wiley.com/doi/full/10.1002/%28SICI%291096-9071%28199704%2951%3A4%3C319%3A%3AAID-JMV10%3E3.0.CO%3B2-D
Clements-Mann ML, Makhene MK, Mrukowicz J, et al. Safety and immunogenicity of live attenuated human-bovine (UK) reassortant rotavirus vaccines with VP7-specificity for serotypes 1, 2, 3 or 4 in adults, children and infants. Vaccine. 1999;17(20-21):2715-2725. Available from https://pubmed.ncbi.nlm.nih.gov/10418923/
Clements-MannLou ML, Dudas R, Hoshino Y, et al. Safety and immunogenicity of live attenuated quadrivalent human-bovine (UK) reassortant rotavirus vaccine administered with childhood vaccines to infants. Vaccine. 2001;19(32):4676-4684. Available from https://pubmed.ncbi.nlm.nih.gov/11535316/
Kapikian AZ, Simonsen L, Vesikari T, et al. A hexavalent human rotavirus-bovine rotavirus (UK) reassortant vaccine designed for use in developing countries and delivered in a schedule with the potential to eliminate the risk of intussusception. J Infect Dis. 2005;192(Suppl 1):S22-S29. Available from https://pubmed.ncbi.nlm.nih.gov/16088801/
Zade JK, Kulkarni PS, Desai SA, Sabale RN, Naik SP, Dhere RM. Bovine rotavirus pentavalent vaccine development in India. Vaccine. 2014;32(S1):A124-A128. Available from https://pubmed.ncbi.nlm.nih.gov/25091665/
Dhingra MS, Kundu R, Gupta M, et al. Evaluation of safety and immunogenicity of a live attenuated tetravalent (G1-G4) Bovine-Human Reassortant Rotavirus vaccine (BRV-TV) in healthy Indian adults and infants. Vaccine. 2014;32(S1):A117-A123. Available from https://pubmed.ncbi.nlm.nih.gov/25091664/
Do Carmo GMI, Yen C, Cortes J, et al. Decline in diarrhea mortality and admissions after routine childhood rotavirus immunization in Brazil: a time-series analysis. PLoS Med. 2011;8(4):11.
Glass RI, Jiang B, Parashar U. The future control of rotavirus disease: can live oral vaccines alone solve the rotavirus problem? Vaccine. 2018;36(17):2233-2236. Available from https://pubmed.ncbi.nlm.nih.gov/29567032/
Yen C, Healy K, Tate JE, et al. Rotavirus vaccination and intussusception - science, surveillance, and safety: a review of evidence and recommendations for future research priorities in low and middle income countries. Hum Vaccines Immunother. 2016;12:2580-2589. Available from https://pubmed.ncbi.nlm.nih.gov/27322835/
Ward RL, McNeal MM. VP6: a candidate rotavirus vaccine. J Infect Dis. 2010;202(Suppl 1):S101-S107. Available from https://pubmed.ncbi.nlm.nih.gov/20684688/
Patel M, Shane AL, Parashar UD, Jiang B, Gentsch JR, Glass RI. Oral rotavirus vaccines: how well will they work where they are needed most? J Infect Dis. 2009;200(s1):S39-S48. Available from https://academic.oup.com/jid/article-lookup/doi/10.1086/605035
Groome MJ, Koen A, Fix A, et al. Safety and immunogenicity of a parenteral P2-VP8-P[8] subunit rotavirus vaccine in toddlers and infants in South Africa: a randomised, double-blind, placebo-controlled trial. Lancet Infect Dis. 2017;17(8):843-853.
Groome MJ, Fairlie L, Morrison J, et al. Safety and immunogenicity of a parenteral trivalent P2-VP8 subunit rotavirus vaccine: a multisite, randomised, double-blind, placebo-controlled trial. Lancet Infect Dis. 2020;20(7):851-863. Available from www.thelancet.com/infection
Jiang B, Gentsch JR, Glass RI. Inactivated rotavirus vaccines: a priority for accelerated vaccine development. Vaccine. 2008;26:6754-6758. Available from https://pubmed.ncbi.nlm.nih.gov/18951937/
Wang Y, Azevedo M, Saif LJ, Gentsch JR, Glass RI, Jiang B. Inactivated rotavirus vaccine induces protective immunity in gnotobiotic piglets. Vaccine. 2010;28(33):5432-5436. Available from https://pubmed.ncbi.nlm.nih.gov/20558244/
Jiang B, Wang Y, Glass RI. Does a monovalent inactivated human rotavirus vaccine induce heterotypic immunity? Hum Vaccines Immunother. 2013;9:1634-1637. Available from https://pubmed.ncbi.nlm.nih.gov/23744507/
Moon S, Wang Y, Edens C, Gentsch JR, Prausnitz MR, Jiang B. Dose sparing and enhanced immunogenicity of inactivated rotavirus vaccine administered by skin vaccination using a microneedle patch. Vaccine. 2013;31(34):3396-3402. Available from https://pubmed.ncbi.nlm.nih.gov/23174199/
Bertolotti-Ciarlet A, Ciarlet M, Crawford SE, Conner ME, Estes MK. Immunogenicity and protective efficacy of rotavirus 2/6-virus-like particles produced by a dual baculovirus expression vector and administered intramuscularly, intranasally, or orally to mice. Vaccine. 2003;21(25-26):3885-3900. Available from https://pubmed.ncbi.nlm.nih.gov/12922123/
Lappalainen S, Pastor AR, Malm M, et al. Protection against live rotavirus challenge in mice induced by parenteral and mucosal delivery of VP6 subunit rotavirus vaccine. Arch Virol. 2015;160(8):2075-2078. Available from pmc/articles/PMC4532722/?report=abstract
Tamminen K, Lappalainen S, Huhti L, Vesikari T, Blazevic V. Trivalent combination vaccine induces broad heterologous immune responses to norovirus and rotavirus in mice. In: Zhou P, ed. PLoS One. 2013;8(7)e70409. Available from https://dx.plos.org/10.1371/journal.pone.0070409
WHO. Rotavirus vaccines. WHO position paper-January 2013. Relev Epidemiol Hebd. 2013;88(5):49-64. Available from http://www.ncbi.nlm.nih.gov/pubmed/23424730
WHO. Rotavirus Immunization Coverage; 2020. [cited 2020 Oct 9]. Available from http://www.who.int/gho/immunization/rotavirus/en/
GAVI. Rotavirus Vaccine Support. 2020. [cited 2020 Oct 9]. Available from https://www.gavi.org/types-support/vaccine-support/rotavirus
Folorunso OS, Sebolai OM. Overview of the development, impacts, and challenges of live-attenuated oral rotavirus vaccines. Vaccines. 2020;8(3):1-64.
Portnoy A, Ozawa S, Grewal S, et al. Costs of vaccine programs across 94 low- and middle-income countries. Vaccine. 2015;33(S1):A99-A108.
Burnett E, Parashar UD, Tate JE. Real-world effectiveness of rotavirus vaccines, 2006-19: a literature review and meta-analysis. Lancet Glob Health. 2020;8(9):e1195-e1202. Available from www.thelancet.com/lancetgh
Abou-Nader AJ, Sauer MA, Steele AD, et al. Global rotavirus vaccine introductions and coverage: 2006 - 2016. Hum Vaccines Immunother. 2018;14(9):2281-2296. https://doi.org/10.1080/21645515.2018.1470725
Lamberti LM, Ashraf S, Walker CLF, Black RE. A systematic review of the effect of rotavirus vaccination on diarrhea outcomes among children younger than 5 years. Pediatr Infect Dis J. 2016;35:992-998. Available from https://pubmed.ncbi.nlm.nih.gov/27254030/
Parashar UD, Johnson H, Steele AD, Tate JE. Health impact of rotavirus vaccination in developing countries: progress and way forward. Clin Infect Dis. 2016;62(suppl 2):S91-S95. Available from https://academic.oup.com/cid/article-lookup/doi/10.1093/cid/civ1015
Komoto S, Maeno Y, Tomita M, et al. Whole genomic analysis of a porcine-like human G5P[6] rotavirus strain isolated from a child with diarrhoea and encephalopathy in Japan. J Gen Virol. 2013;94(PART 7):1568-1575. Available from https://www.microbiologyresearch.org/content/journal/jgv/10.1099/vir.0.051011-0
Hoxie I, Dennehy JJ. Intragenic recombination influences rotavirus diversity and evolution. Virus Evol. 2020;6(1):vez059. Available from. https://academic.oup.com/ve/article/6/1/vez059/5701449
Bibera GL, Chen J, Pereira P, Benninghoff B. Dynamics of G2P[4] strain evolution and rotavirus vaccination: a review of evidence for Rotarix. Vaccine. 2020;38:5591-5600.
Roczo-Farkas S, Kirkwood CD, Cowley D, et al. The impact of rotavirus vaccines on genotype diversity: a comprehensive analysis of 2 decades of australian surveillance data. J Infect Dis Immun. 2018;218(4):546-554. Available from https://academic.oup.com/jid/article/218/4/546/5001444
Leshem E, Lopman B, Glass R, et al. Distribution of rotavirus strains and strain-specific effectiveness of the rotavirus vaccine after its introduction: a systematic review and meta-analysis. Lancet Infect Dis. 2014;14(9):847-856. Available from http://www.thelancet.com/article/S1473309914708321/fulltext
Markkula J, Hemming-Harlo M, Salminen MT, et al. Rotavirus epidemiology 5-6 years after universal rotavirus vaccination: persistent rotavirus activity in older children and elderly. Infect Dis. 2017;49(5):388-395. Available from https://pubmed.ncbi.nlm.nih.gov/28067093/
Zeller M, Rahman M, Heylen E, et al. Rotavirus incidence and genotype distribution before and after national rotavirus vaccine introduction in Belgium. Vaccine. 2010;28(47):7507-7513. Available from http://linkinghub.elsevier.com/retrieve/pii/S0264410X10012995
Zeller M, Nuyts V, Heylen E, et al. Emergence of human G2P[4] rotaviruses containing animal derived gene segments in the post-vaccine era. Sci Rep. 2016;6:36841. Available from http://creativecommons.org/licenses/by/4.0/
Gentsch JR, Laird AR, Bielfelt B, et al. Serotype diversity and reassortment between human and animal rotavirus strains: implications for rotavirus vaccine programs. J Infect Dis. 2005;192:S146-S159. Available from https://oup.silverchair-cdn.com/oup/backfile/Content_public/Journal/jid/192/Supplement_1/10.1086/4314992/192-Supplement_1-S146.pdf?Expires=1498131819&Signature=VF~lPL0kxpW2nc8oYwxgqMzMIQZeC0uHeMeOqJnwdEcWXY06ncs3Vh3zQRv-THMUq4veYERQWrjHY18cmrdakJE-CMsvKf
Aida S, Nahar S, Paul SK, et al. Whole genomic analysis of G2P[4] human Rotaviruses in Mymensingh, north-central Bangladesh. Heliyon. 2016;2(9):e00168.
Bertol JW, Fregolente MCD, Caruzo TAR, et al. Molecular characterisation of the NSP4 gene of group A human rotavirus G2P[4] strains circulating in São Paulo, Brazil, from 1994 and 2006 to 2010. Mem Inst Oswaldo Cruz. 2015;110(6):786-792. Available from http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0074-02762015000600786&lng=en&nrm=iso&tlng=en
Roy S, Rungsrisuriyachai K, Esona MD, et al. G2P[4]-RotaTeq reassortant rotavirus in vaccinated child, United States Emerg Infect Dis. 2015;21:2103-2104. Available from https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4622260/
Strydom A, João ED, Motanyane L, et al. Whole genome analyses of DS-1-like rotavirus A strains detected in children with acute diarrhoea in southern Mozambique suggest several reassortment events. Infect Genet Evol. 2019;69:68-75.
Agbemabiese CA, Nakagomi T, Doan YH, et al. Genomic constellation and evolution of Ghanaian G2P[4] rotavirus strains from a global perspective. Infect Genet Evol. 2016;45:122-131.
Pitzer VE, Bilcke J, Heylen E, et al. Did large-scale vaccination drive changes in the circulating rotavirus population in Belgium? Sci Rep. 2015;5:18585. Available from http://www.ncbi.nlm.nih.gov/pubmed/26687288
Jere KC, Chaguza C, Bar-Zeev N, et al. Emergence of double- and triple-gene reassortant G1P[8] rotaviruses possessing a DS-1-like backbone after rotavirus vaccine introduction in Malawi. In: Gallagher T, ed. J Virol. 2018;92(3):e01246-17. Available from http://www.ncbi.nlm.nih.gov/pubmed/29142125
Komoto S, Tacharoenmuang R, Guntapong R, et al. Reassortment of human and animal rotavirus gene segments in emerging DS-1-like G1P[8] rotavirus strains. PLoS One. 2016;11(2):e0148416. Available from https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0148416&type=printable
Yamamoto SP, Kaida A, Kubo H, Iritani N. Gastroenteritis outbreaks caused by a DS-1-like G1P[8] rotavirus strain, Japan, 2012-2013. Emerg Infect Dis. 2014;20(6):1030-1033. Available from https://doi.org/10.3201/eid2006.131326
Nakagomi T, Nguyen MQ, Gauchan P, et al. Evolution of DS-1-like G1P[8] double-gene reassortant rotavirus A strains causing gastroenteritis in children in Vietnam in 2012/2013. Arch Virol. 2012;162(3):739-748. Available from https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5329091/pdf/705_2016_Article_3155.pdf
Correia JB, Patel MM, Nakagomi O, et al. Effectiveness of monovalent rotavirus vaccine (rotarix) against severe diarrhea caused by serotypically unrelated G2P[4] strains in Brazil. J Infect Dis. 2010;201(3):363-369. Available from https://pubmed.ncbi.nlm.nih.gov/20047501/
Breiman RF, Zaman K, Armah G, et al. Analyses of health outcomes from the 5 sites participating in the Africa and Asia clinical efficacy trials of the oral pentavalent rotavirus vaccine. Vaccine. 2012;30:A24-A29. Available from http://www.ncbi.nlm.nih.gov/pubmed/22520132
Duncan Steele A, Neuzil KM, Cunliffe NA, et al. Human rotavirus vaccine RotarixTM provides protection against diverse circulating rotavirus strains in African infants: a randomized controlled trial. BMC Infect Dis. 2012;12:213. Available from http://www.biomedcentral.com/1471-2334/12/213
Clarke E, Desselberger U. Correlates of protection against human rotavirus disease and the factors influencing protection in low-income settings. Mucosal Immunol. 2015;8:1-17. Available from www.nature.com/mi
Svensson L, Sheshberadaran H, Vesikari T, Norrby E, Wadell G. Immune response to rotavirus polypeptides after vaccination with heterologous rotavirus vaccines (RIT 4237, RRV-1). J Gen Virol. 1987;68(7):1993-1999. Available from https://pubmed.ncbi.nlm.nih.gov/3037019/
Flores J, Perez-Schael I, Blanco M, et al. Reactions to and antigenicity of two human-rhesus rotavirus reassortant vaccine candidates of serotypes 1 and 2 in Venezuelan infants. J Clin Microbiol. 1989;27(3):512-518. Available from https://pubmed.ncbi.nlm.nih.gov/2541168/
Ward RL. Possible mechanisms of protection elicited by candidate rotavirus vaccines as determined with the adult mouse model. Viral Immunol. 2003;16:17-24. Available from https://pubmed.ncbi.nlm.nih.gov/12725685/
Kirkwood CD. Genetic and antigenic diversity of human rotaviruses: potential impact on vaccination programs. J Infect Dis. 2010;202(S1):S43-S48. Available from https://academic.oup.com/jid/article-lookup/doi/10.1086/653548